Spontaneous canine transmissible venereal tumor: cell morphology and influence on P-glycoprotein expression

The present study aimed to determine P-glycoprotein expression according to TVT cell morphology in 42 dogs with confirmed TVT, classified into lymphocytoid, plasmocytoid, and mixed. The chemotherapy efficiency was investigated along with its relation to P-glycoprotein expression in tumoral cells, evaluated by immunocytochemistry, considering positive tumors more than 10% stained. Among the samples collected, 50.00% possessed plasmocytoid morphology, 18.63% lymphocytoid, and 31.37% mixed. The plasmocytoid presented greater immunoreactivity to the anti-P-glycoprotein antibody in relation to the lymphocytoid. It was observed that the plasmocytoid was less sensitive to chemotherapy. The cases that had partial clinical response in the lymphocytoid were less compared with those in the plasmocytoid. Therefore, we can infer that the plasmocytoid presents a potential drug resistance. Based on this study, it can be concluded that the plasmocytoid presents a higher frequency of partial clinical response than the lymphocytoid and mixed, possibly through its higher percentage of anti-P-glycoprotein antibody expression.

Spontaneous canine transmissible venereal tumor: cell morphology and influence on P-glycoprotein expression

The present study aimed to determine P-glycoprotein expression according to TVT cell morphology in 42 dogs with confirmed TVT, classified into lymphocytoid, plasmocytoid, and mixed. The chemotherapy efficiency was investigated along with its relation to P-glycoprotein expression in tumoral cells, evaluated by immunocytochemistry, considering positive tumors more than 10% stained. Among the samples collected, 50.00% possessed plasmocytoid morphology, 18.63% lymphocytoid, and 31.37% mixed. The plasmocytoid presented greater immunoreactivity to the anti-P-glycoprotein antibody in relation to the lymphocytoid. It was observed that the plasmocytoid was less sensitive to chemotherapy. The cases that had partial clinical response in the lymphocytoid were less compared with those in the plasmocytoid. Therefore, we can infer that the plasmocytoid presents a potential drug resistance. Based on this study, it can be concluded that the plasmocytoid presents a higher frequency of partial clinical response than the lymphocytoid and mixed, possibly through its higher percentage of anti-P-glycoprotein antibody expression.

___

  • Albanese, F., Poli, A., Millanta, F., Abramo, F.: Primary cutaneous extragenital canine transmissible venereal tumour with Leishmania-Iaden neoplastic cells: a further suggestion of histiocytic origin? Vet. Dermatol., 2002; 13: 243-246.
  • Amaral, A.S., Bassani-Silva, S., Ferreira, I., Fonseca, L.S., Andrade, F.H.E., Gaspar, L.F.J., Rocha, N.S.: Cytomorphological characterization of transmissible canine venereal tumor. Rev. Port. Cienc. Vet., 2007; 102: 253-260. 9. Rogers, K.S.: Transmissible venereal tumour. Compend. Contin. Educ., 1997; 19: 1036-1045.
  • Bassani-Silva, S., Sforcin, J.M., Amaral, A.S., Gaspar, L.F.J., Rocha, N.S.: Propolis effect in vitro on canine transmissible venereal tumor cells. Rev. Port. Cienc. Vet., 2007; 102: 261-265.
  • Dass, L.L., Sahay, P.N.: Surgical treatment of canine transmissible venereal tumor – a retrospective study. Indian Vet. J., 1989; 66: 255-258.
  • Panchbhai, V.S., Karpe, A.G., Kulkarni, G.B., Kulkarni, P.E.: Use of autogenous vaccine in transmissible canine venereal tumor. Indian Vet. J., 1990; 67: 983-984.
  • Rogers, K.S., Walker, M.A., Dillon, H.B.: Transmissible venereal tumor: a retrospective study of 29 cases. J. Amer. Anim. Hosp. Assoc., 1998; 34: 463-470.
  • Erünal-Maral, N., Findik, M., Aslan, S.: Use of exfoliative cytology for diagnosis of transmissible venereal tumour and controlling the recovery period in the bitch. Dtsch. Tierarztl. Wochenschr, 2000; 107: 175-180.
  • Lefebvre, G.N.F., Bonamin, L.V., Oliveira, C.M.: Treatment of transmissible venereal tumor (tvt) in dogs with Viscum album (Mistletoe) associated to chemotherapy. Clínica Veterinária, 2007; 70: 78-86. (article in Portuguese with an abstract in English).
  • Camacho, A.A., Laus, J.L.: Study on the efficiency of vincristine in the treatment of dogs infected with transmissible venereal tumor. Ars Veterinaria, 1987; 3: 37-42.
  • Sem, T.B., Mitra, M., Guha, C.: Treatment of canine transmissible venereal tumour with ciclophosphamide: a case report. Indian Vet. J., 1994; 71: 1120-1122.
  • Singh, J., Rana, J.S., Sood, N., Pangawkar, G.R.; Gupta, P.P.: Effect of geriforte supplementation on blood chemistry in transmissible venereal tumor affected dogs treated with vincristine sulphate. Indian Vet. J., 1997; 74: 420-421.
  • Moore, A.S., Leveille, C.R., Reimann, K.A., Shu, H., Arias, I.M.: The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Invest., 1995; 13: 475-479.
  • Alexandrova, R.: Multidrug resistance and P-glycoprotein. Exp. Pathol. Parasitol., 1998; 1: 62-66.
  • Baldini, N., Scotlandi, K., Barbanti-Bròdano, G., Manara, M.C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., Serra, M.: Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl. J. Med., 1995; 333: 1380-1384.
  • Ginn, P.E.: Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Vet. Pathol., 1996; 33: 533-541.
  • Thomas, H., Coley, H.: Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P- glycoprotein. Cancer Control., 2003; 10: 159-165.
  • Mealey, K.L., Barhoumi, R., Rogers, K., Kochevar, D.T.: Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line. Cancer Lett., 1998; 126: 187-192.
  • Miyoshi, N., Tojo, E., Oishi, A., Fujiki, M., Misumi, K., Sakamoto, H., Kameyama, K., Shimizu, T., Yasuda, N.: Immunohistochemical detection of P-glycoprotein (PGP) and multidrug resistance-associated protein (MRP) in canine cutaneous mast cell tumors. J. Vet. Med. Sci., 2002; 64: 531-533.
  • Amaral, A.S., Gaspar, L.F.J., Bassani-Silva, S., Rocha, N.S.: Cytological diagnostic of transmissible venereal tumor in the Botucatu region, Brazil (descriptive study: 1994-2003). Rev. Port. Cienc. Vet., 2004; 99: 167-171. (article in Portuguese with an abstract in English).
  • Montero, C.: The antigen-antibody reaction in immunohistochemistry. J. Histochem. Cytochem., 2003; 51: 1- 4.
  • Moral, R.G., Valle, F.O., Andujar, M., Aguilar, M., Lucena, M.A., Hidalgo, L.J., Ramirez, C., Medina-Cano, M.T., Aguilar, D., Morales, M.G.: Relationship between P-glycoprotein expression and cyclosporin A in kidney. Am. J. Pathol., 1995; 146: 398-408.
  • Lee, J.J., Hughes, C.S., Fine, R.L., Page, R.L.: Glycoprotein expression in canine lymphoma. Cancer, 1996; 77: 1892-1898.
  • Bergman, P.J., Ogilvie, G.K., Powers, B.E.: Monoclonal antibody C219 immunochemistry against P-glycoprotein: sequential analysis and predictive ability in dogs with lymphoma. J. Vet. Intern. Med., 1996; 10: 354-359.
Turkish Journal of Veterinary and Animal Sciences-Cover
  • ISSN: 1300-0128
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK